What is the main purpose of this 10-Q/A filing from Johnson & Johnson?

The primary purpose of this 10-Q/A (Quarterly Report Amendment) filing is to provide an updated or amended view of Johnson & Johnson's financial performance and operational status for the fiscal quarter ending June 29, 1996. Amendments are typically filed to correct errors, provide additional disclosures, or refine previously reported information, ensuring greater accuracy and completeness for investors.

What specific financial information can I expect to find in this filing?

While the provided excerpt does not contain detailed financial statements, a 10-Q/A filing generally includes unaudited financial results such as income statements, balance sheets, and cash flow statements for the quarter. It also typically provides Management's Discussion and Analysis (MD&A) of financial condition and results of operations, discussing key business trends, revenue sources, expenses, and any significant events impacting the company's performance during the period.

Why is it important for investors to review an amended 10-Q filing (10-Q/A)?

An amended filing (10-Q/A) is important for investors because it signifies that previously submitted information may have been inaccurate, incomplete, or required further clarification. Reviewing the amendment allows investors to access the most current and accurate data available, helping them make informed investment decisions based on the latest reported financial position and operational insights of Johnson & Johnson.

Where can I find the complete 10-Q/A filing for Johnson & Johnson dated August 8, 1996?

To access the complete filing, investors would typically need to visit the SEC's EDGAR (Electronic Data Gathering, Analysis, and Retrieval) database. Searching for Johnson & Johnson (JNJ) with the filing date of August 8, 1996, and the form type 10-Q/A will provide access to the full document, including all detailed financial statements and disclosures.

JNJ 10-Q Quarterly Report Q2 FY1996 — Revenue, Net Income, EPS

Summary

Johnson & Johnson (JNJ) filed an amendment to its Form 10-Q for the period ending June 29, 1996, on August 8, 1996. This filing provides an update on the company's financial performance and operations during the second quarter of fiscal year 1996. Investors should note the details within this report, as they offer insight into the company's sales, earnings, and any significant developments or changes that may have impacted its business during the reporting period. The amended filing suggests that JNJ is committed to providing accurate and up-to-date information to its shareholders. While specific financial figures and operational details are not fully provided in the excerpt, the nature of a 10-Q/A filing indicates a review of the company's financial health and strategic positioning in the market, crucial for understanding its ongoing value and future prospects. Investors are encouraged to examine the full document for comprehensive details on the company's performance and any disclosures made.

Key Highlights

1Johnson & Johnson (JNJ) filed an amended 10-Q report for the quarter ending June 29, 1996.
2The filing was made on August 8, 1996, indicating a potential update or correction to previous disclosures.
3The report covers the company's financial performance and operational status for the second quarter of 1996.
4This filing provides key information for investors regarding JNJ's business activities during the specified period.
5As an amended filing, it may contain revised or additional details compared to the original 10-Q submission.
6Investors can gain insights into JNJ's market position and financial health through this SEC filing.

JOHNSON & JOHNSON Quarterly Report (Amendment) for Q2 Ended Jun 30, 1996

Summary

Key Highlights

Frequently Asked Questions